These articles are part of the Gridlex Weekly Newsletter focused on Biopharma and Medical Device technology, analytics, and operational topics. Please email gridlexnewsletter@gridlex21.com to join this newsletter and receive updates (not more than once per week).
In the biopharmaceutical industry, the role of precise and effective data management is pivotal. Central to this is Master Data Management (MDM), which plays a crucial part in commercial operations driven by data-centric decision-making. Within the scope of MDM, soft merge and hard merge emerge as key methodologies, impacting how data is consolidated and utilized in this highly regulated sector
Read more...
Despite significant investments in developing powerful analytics capabilities aimed at driving sales and improving decision-making, a surprising disconnect exists when it comes to delivering these insights to the front lines. Biopharma sales reps, the individuals most in need of actionable data, often find themselves without the critical analytics that could make their daily tasks more effective.
Read more...
Call Recording Forms in many Biopharma CRMs often fall short of their potential utility. These forms are typically used merely for administrative purposes—logging call details, outcomes, and perhaps noting some cursory observations. But they could serve a more critical function. Leveraging advanced CRM functionalities like those found in Gridlex's Biopharma CRM can transform these call recording forms into real-time coaching and learning systems.
Read more...
A Biopharma CRM has many elements to make it successful for companies. However, the two most important things for the daily activities and the most used features and value addition to reps are: 1) How Should I Call On? 2) What Should I Tell Them When I Call On Them?
Read more...
The biopharma industry faces a unique challenge in blending analytics, marketing, and sales into a cohesive strategy, particularly when targeting healthcare providers. While large biopharma organizations may have the resources to integrate machine learning models for next-best-action recommendations or suggested, most companies lack the scale to implement such sophisticated systems. As a result, the pendulum often swings to the other extreme—relying on simplistic decile volume-based targeting.
Read more...
In Biopharma commercial operations, minor data inaccuracies can lead to major complications as data moves from CRM to MDM and then to Reporting & Analytics. Some consequences of data pollution include misattributed sales, skewed analytics, misguided marketing efforts, flawed geographical data, incorrect event records, and compliance risks.
Read more...
Navigating through the intricacies of CRM deployment in the Biopharma sector can be daunting, but our latest guide paves the way for seamless adoption and optimization. Delve into real-world scenarios, probing vendor questions, and succinct solutions that unmask the full potential of your CRM system, tailored explicitly for Biopharma professionals. Explore strategic insights, data management prowess, and change deployment models with us, ensuring you wield your CRM's capabilities not just as a tool but as an ally in steering through the Biopharma commercial landscape.
Read more...
The Physician Payments Sunshine Act became law as a part of the Affordable Care Act. This act was established with the aim of improving transparency among patients about the financial interactions between life science organizations and Healthcare Professionals (HCPs). The Sunshine Act requires distributors and manufacturers of drugs/devices/supplies to report payments and other transfer of value made to physicians and teaching hospitals. 2021 ushers in new changes to the data collected which includes the addition of Non-Physician Practitioners. This adds the burden on representatives who report data. Gridlex provides tools including the Sunshine Act Reporting Management App that …
Read more...